|
No one seems to know what the rules of social media for life sciences are, including, some might say, the FDA itself. The agency's piecemeal approach to establishing a social media policy over the past five years consists of four narrow guidances that don't begin to cover all the issues.
|
The agency just can't keep pace with this ever-expanding phenomenon. But that hasn't kept it from issuing warning letters to drug and devicemakers for perceived violations.
Social Media Accountability for Drug and Devicemakers gives you an understanding of how to use social media for product promotion without running afoul of the FDA:
- What online communications the FDA holds firms accountable for
- The differences between the FDA's definitions of regulated and unregulated content and solicited and unsolicited communication
- How to present required risk information in limited space
- Correcting third-party misinformation
- When use of hyperlinks is appropriate
- Monitoring and reporting adverse events
Using social media to reach your audience can be very effective if you're creative and careful. Order your copy of Social Media Accountability for Drug and Devicemakers today.
PDF Edition
|
|
Available Format |
|
PDF Edition — $397
Who Will Benefit
- Business managers
- Senior management
- Marketing staff
- Regulatory/legal affairs
- Communications department
Multi-user Access
Save money with a license agreement allowing significant numbers of users access to an electronic version of this book. For multi-user access to multiple titles, FDAnews offers the FDAnews Online Library — a personalized collection of FDAnews publications that is fully searchable. Contact Customer Service for a quote or more information.
Our Guarantee
Not satisfied with your publication? For the PDF version, you must notify FDAnews within 24 hours of receipt of purchase and we will refund 100 percent of your purchase price.
|
|
|
